VAERS 1848522
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8203
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 06.11.2021
- Impfdatum
- 23.02.2021
- Beginn
- 01.06.2021
- Tage bis Beginn
- 98,0
- Dosis
- 2
- Route/Site
- - / RA
Symptomtext
Idiopathic Pulm fibrosis; Gi distention/loss of ability to eat; loss of ability to eat; Hbg from 11 to 8.9; dramatic drop in iron/ferritin; dramatic drop in iron/ferritin; auto-immune inflammatory response; auto-immune inflammatory response; hair loss; pale/pallor appearance; short of breath; This is a spontaneous report from a contactable nurse (patient). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 23Feb2021 17:00 (Lot Number: EN8203), at the age of 73-years-old, as dose 2, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Medical history included Idiopathic thrombocytopenic purpura from 2003, lupus from 2004, hypertension from 2020. Concomitant medications included amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported; hydroxychloroquine (HYDROXYCHLOROQUINE) taken for an unspecified indication, start and stop date were not reported, and Multivits. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 28Jan2021 17:00 (Lot Number: EN6203), at the age of 73-years-old, as dose 1, single for covid-19 immunisation. The patient has known allergies to penicillin and tetracycline. The patient reported having lupus and 3-4 months after last dose, in Jun2021 had an auto-immune inflammatory response, hair loss, pale/pallor appearance, short of breath. Later labs and tests showed in Aug2021 drop in hemoglobin (Hbg) from 11 to 8.9./ dramatic drop in iron/ferritin, gastrointestinal (GI) distention/loss of ability to eat, and computerized tomography (CT) scan showed new development of Idiopathic Pulmonary fibrosis. The events were reported as non serious. The adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care visit. Treatment was received for the events. And new consults with primary, Hematology, GI (gastrointestinal), Rheumatology was required. The patient was recovering from the events.; Sender's Comments: Based on the information available, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Test Date: 202108; Test Name: iron; Result Unstructured Data: Test Result:dramatic drop; Test Date: 202108; Test Name: CT scan; Result Unstructured Data: Test Result:idiopathic pulmonary fibrosis; Test Name: hbg; Result Unstructured Data: Test Result:11; Test Date: 202108; Test Name: hbg; Result Unstructured Data: Test Result:8.9; Comments: from 11 to 8.9; Test Date: 202108; Test Name: ferritin; Result Unstructured Data: Test Result:dramatic drop
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypertension; Idiopathic thrombocytopenic purpura (ITP); Lupus syndrome (lupus); Penicillin allergy
- Andere Medikamente
- AMLODIPINE; HYDROXYCHLOROQUINE
- Allergien
- -
- Vorherige Impfungen
- -